InvestorsHub Logo
Followers 70
Posts 13152
Boards Moderated 0
Alias Born 06/03/2015

Re: Investor2014 post# 413930

Friday, 05/05/2023 10:25:59 AM

Friday, May 05, 2023 10:25:59 AM

Post# of 472910
Like I said... the means scores that met all endpoints exist and will be provided to the regulatory agencies as baseline evidence for approval. However, Anavex is going one better by highlighting the patients who have IMPROVED... the Super Responders... and how blarcamesine is an actual disease-modifying drug.

No need for another P3... it'll be a P4.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News